Anti-Interleukin 23 as a Targeted Treatment Option for Pityriasis Rubra Pilaris

This case report describes a targeted treatment option in a patient with pityriasis rubra pilaris using blockade of the interleukin 23–helper T cell 17 pathway.

http://ift.tt/2jfZyuY